Ardent Health
ARDT
10.88
+0.20
+1.87%
Ardent Health
US · ARDT
#2983 by market cap
Listed 2024
10.88
+0.20
+1.87%
Live - 5344 symbols - heartbeat 361s ago
· 2026-10-08 04:00
Pre-market
10.81
-0.61%
After-hours
10.88
0.00%
Overnight
10.75
-1.19%
- Market cap
- 1.53B
- P/E (TTM)i
- 19.78
- P/Bi
- 1.14
- EPSi
- 0.96
- Div yieldi
- 0.00%
- 52W posi
- 41%
Reader sentiment
Are you bullish or bearish on ARDT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Accumulating
- The number of reporting institutions decreased by 3 in the most recent period (2026/Q3).
- Total institutional ownership rose 0.6 percentage points.
Institutional ownership
- Held by institutions
- 98.46% +0.57pp
- Institutions
- 168 -3
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
VC/PE Fund54.77%
Public Company22.35%
Mutual Fund10.01%
REIT6.62%
Hedge Fund4.03%
Individual/Insider1.72%
Private Company0.42%
Government Pension Fund0.24%
Top holders
Equity Group Investments
54.77%
Pure Health Holding PJSC
21.46%
Ventas, Inc.
6.62%
BlackRock
1.54%
Columbia Management Investment Advisers, LLC
1.50%
GoldenTree Asset Management LP
1.12%
AQR Capital Management
1.02%
Bridgeway Capital Management, LLC
0.99%
Vanguard Capital Management, LLC
0.80%
Castleknight Management LP
0.76%
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 32 buys · 18 sells
| Name | Role | Stake |
|---|---|---|
| Pure Health Holding PJSC | -- | 21.46% |
| Stephen Petrovich | Executive VP, General Counsel, Chief Legal Officer & Secretary | 0.75% |
| Martin Bonick | Chief Executive Officer | 0.39% |
| Alfred Lumsdaine | Chief Financial Officer | 0.11% |
| David Byers | Chief Accounting Officer | 0.07% |
| Peter C. Bynoe | Director | 0.07% |
| William Goodyear | Director | 0.07% |
| Ellen Havdala | Director | 0.07% |
| Robert Webb | Director | 0.04% |
| David Schultz | President of Hospital Operations | 0.03% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-24 | Alfred Lumsdaine | Chief Financial Officer | Sale to Issuer | -3,389 | $10.54 |
| 2026-09-24 | Stephen Petrovich | Executive VP, General Counsel, Chief Legal Officer & Secretary | Sale to Issuer | -788 | $10.54 |
| 2026-09-24 | David Byers | Chief Accounting Officer | Sale to Issuer | -524 | $10.54 |
| 2026-08-26 | Martin Bonick | Chief Executive Officer | Intent to Sell (Form 144) | -35,930 | $11.08 |
| 2026-08-24 | Martin Bonick | Chief Executive Officer | Intent to Sell (Form 144) | -35,930 | $11.17 |
| 2026-08-19 | Martin Bonick | Chief Executive Officer | Intent to Sell (Form 144) | -35,930 | $10.50 |
| 2026-08-17 | Martin Bonick | Chief Executive Officer | Intent to Sell (Form 144) | -35,930 | $10.95 |
| 2026-06-30 | David Caspers | Chief Operating Officer | Other Acquisition | +103,653 | -- |
| 2026-06-04 | Alfred Lumsdaine | Chief Financial Officer | Open Market Acquisition | +10,000 | $8.81 |
| 2026-06-04 | Robert DeMichiei | Director | Open Market Acquisition | +11,260 | $8.73 |
| 2026-03-31 | Mark Sotir | Chairperson | Other Acquisition | +14,231 | -- |
| 2026-03-31 | William Goodyear | Director | Other Acquisition | +14,231 | -- |
| 2026-03-31 | Peter C. Bynoe | Director | Other Acquisition | +14,231 | -- |
| 2026-03-31 | Robert Webb | Director | Other Acquisition | +14,231 | -- |
| 2026-03-31 | Alfred Lumsdaine | Chief Financial Officer | Sale to Issuer | -6,891 | $8.56–8.67 |
| 2026-03-31 | Alfred Lumsdaine | Chief Financial Officer | Other Acquisition | +53,846 | -- |
| 2026-03-31 | Stephen Petrovich | Executive VP, General Counsel, Chief Legal Officer & Secretary | Sale to Issuer | -3,233 | $8.56–8.67 |
| 2026-03-31 | Stephen Petrovich | Executive VP, General Counsel, Chief Legal Officer & Secretary | Other Acquisition | +24,904 | -- |
| 2026-03-31 | Ellen Havdala | Director | Other Acquisition | +14,231 | -- |
| 2026-03-31 | Robert DeMichiei | Director | Other Acquisition | +14,231 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 04:00:02 · For reference only, not investment advice and not tailored to your situation.